Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
Werte in diesem Artikel
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Cardinal Health (CAH) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.Cardinal Health is a member of our Medical group, which includes 985 different companies and currently sits at #7 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Cardinal Health is currently sporting a Zacks Rank of #2 (Buy).Within the past quarter, the Zacks Consensus Estimate for CAH's full-year earnings has moved 2.8% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.Our latest available data shows that CAH has returned about 32.8% since the start of the calendar year. At the same time, Medical stocks have lost an average of 5.2%. This shows that Cardinal Health is outperforming its peers so far this year.One other Medical stock that has outperformed the sector so far this year is Biotricity Inc. (BTCY). The stock is up 75.9% year-to-date.Over the past three months, Biotricity Inc.'s consensus EPS estimate for the current year has increased 17.9%. The stock currently has a Zacks Rank #2 (Buy).Looking more specifically, Cardinal Health belongs to the Medical - Dental Supplies industry, a group that includes 14 individual stocks and currently sits at #50 in the Zacks Industry Rank. Stocks in this group have lost about 0.7% so far this year, so CAH is performing better this group in terms of year-to-date returns. Biotricity Inc., however, belongs to the Medical Info Systems industry. Currently, this 44-stock industry is ranked #82. The industry has moved +8.2% so far this year.Going forward, investors interested in Medical stocks should continue to pay close attention to Cardinal Health and Biotricity Inc. as they could maintain their solid performance.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cardinal Health, Inc. (CAH): Free Stock Analysis Report Biotricity Inc. (BTCY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Cardinal Health und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Cardinal
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Cardinal
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Cardinal Health Inc.
Analysen zu Cardinal Health Inc.
Datum | Rating | Analyst | |
---|---|---|---|
08.03.2018 | Cardinal Health Equal Weight | Barclays Capital | |
04.12.2017 | Cardinal Health Hold | Deutsche Bank AG | |
19.09.2017 | Cardinal Health Sector Perform | RBC Capital Markets | |
28.04.2017 | Cardinal Health Neutral | Tigress Financial | |
04.04.2017 | Cardinal Health Hold | Needham & Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
03.11.2015 | Cardinal Health Buy | UBS AG | |
03.11.2015 | Cardinal Health Outperform | FBR Capital | |
09.06.2015 | Cardinal Health Buy | UBS AG | |
10.03.2015 | Cardinal Health Outperform | FBR Capital | |
04.03.2015 | Cardinal Health Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
08.03.2018 | Cardinal Health Equal Weight | Barclays Capital | |
04.12.2017 | Cardinal Health Hold | Deutsche Bank AG | |
19.09.2017 | Cardinal Health Sector Perform | RBC Capital Markets | |
28.04.2017 | Cardinal Health Neutral | Tigress Financial | |
04.04.2017 | Cardinal Health Hold | Needham & Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Cardinal Health Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen